Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-06 @ 1:33 PM
Study NCT ID:
NCT02144194
Status:
UNKNOWN
Last Update Posted:
2017-02-09
First Post:
2014-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca
Sponsor:
Cancer Research Group - Collaborative Group, Beirut, Lebanon.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CRG SE036
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None